Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
03/19/1997 | EP0763107A1 Pantropic neurotrophic factors |
03/19/1997 | EP0763106A1 Methods and compositions for treatment of restenosis and cancer using ribozymes |
03/19/1997 | EP0763105A1 Isolated nucleic acid molecule coding for fibroblast activation protein alpha and uses thereof |
03/19/1997 | EP0763100A1 Method of purification of clostridium difficile toxin a and production of mono-specific antibodies |
03/19/1997 | EP0763062A1 New opioid peptide analogs with mixed mu agonist/delta antagonist properties |
03/19/1997 | EP0763061A1 Process and intermediate products for preparing cardiodilatin fragments, and highly purified cardiodilatin fragments |
03/19/1997 | EP0763060A1 Plant genes for sensitivity to ethylene and pathogens |
03/19/1997 | EP0763059A1 Recombinant allergen, fragments thereof, corresponding recombinant dna molecules, vectors and hosts containing the dna molecules, diagnostic and therapeutic uses of said allergens and fragments |
03/19/1997 | EP0763058A1 $i(RPS) GENE FAMILY, PRIMERS, PROBES, AND DETECTION METHODS |
03/19/1997 | EP0763057A1 Method for proliferating and differentiating b cells, and uses thereof |
03/19/1997 | EP0763045A1 Haemopoietic maturation factor |
03/19/1997 | EP0762901A1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING |
03/19/1997 | EP0762897A1 Method of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby |
03/19/1997 | EP0762895A1 Synthetic vaccine for protection against human immunodeficiency virus infection |
03/19/1997 | EP0762894A1 Method of inducing an immune response with a live venezuelan equine encephalitis virus expressing a heterologous immunogen |
03/19/1997 | EP0762892A1 Diphtheria toxin vaccines bearing a mutated r domain |
03/19/1997 | EP0762891A1 Immunogenic pharmaceuticals |
03/19/1997 | EP0762889A1 Heparin-binding protein for the treatment of sepsis and processes for its preparation |
03/19/1997 | EP0762888A1 Copolymer-1 improvements in compositions of copolymers |
03/19/1997 | EP0762887A1 Acylated enol derivatives as prodrugs of elastase inhibitors |
03/19/1997 | EP0762886A1 Icam-1/lfa-1 short-chain peptides and method of using same |
03/19/1997 | EP0762885A1 Glial mitogenic factors, their preparation and use |
03/19/1997 | EP0762881A1 Method and reagents for the treatment of rheumatoid arthritis |
03/19/1997 | EP0762870A1 Virosome-mediated intracellular delivery of therapeutic agents |
03/19/1997 | EP0659191A4 Cloning and expression of pur protein. |
03/19/1997 | EP0626861B1 Treatment for asthma |
03/19/1997 | EP0596881B1 Expression in non-tumoral human lymphoblastoid lines with an integrative vector |
03/19/1997 | EP0561965A4 Enhancement of musculature in animals |
03/19/1997 | EP0445135B1 Immogenically active fractions of borrelia burgdorferi |
03/19/1997 | CN1145641A DNA mutagenesis by random fragmentation and reassembly |
03/19/1997 | CN1145637A Alpha-1-antichymotrypsin analogues having elastase inhibitory activity |
03/19/1997 | CN1145636A Vascular endothelial growth factor 2 |
03/19/1997 | CN1145589A Method for antigen-specific immunoregulation by T-Cell alpha chain |
03/19/1997 | CN1145369A Peptide useful as ligand |
03/19/1997 | CA2182541A1 Novel, ubiquitous potassium-channel proteins and genes for the same |
03/19/1997 | CA2181880A1 Atp-sensitive potassium-channel proteins and their genes |
03/18/1997 | US5612487 Viricides, antigens and tobacco plants |
03/18/1997 | US5612486 Transgenic animals harboring APP allele having swedish mutation |
03/18/1997 | US5612472 Plant promoter |
03/18/1997 | US5612471 Nematode-induced genes in tomato |
03/18/1997 | US5612470 Nucleic acid encoding the growth hormone releasing hormone receptor |
03/18/1997 | US5612469 Enhancement of ribozyme catalytic activity by a neighboring facilitator oligonucleotide |
03/18/1997 | US5612455 Nuclear factors and binding assay |
03/18/1997 | US5612453 Viricides |
03/18/1997 | US5612360 Aromatic n-heterocyclic compounds as hypotensive agents with acid groups, sulfonylcarboxamides or tetrazole groups |
03/18/1997 | US5612318 Control of gene expression by ionizing radiation |
03/18/1997 | US5612314 Nitrosylated neuropeptides |
03/18/1997 | US5612312 (igf-i)insulin-like growth factor i |
03/18/1997 | US5612311 Cyclic peptides |
03/18/1997 | US5612220 Isolated DNA molecule encoding SPRM-1 protein |
03/18/1997 | US5612216 Nucleotide sequence encoding intercellular adhesion molecule-1 and fragments thereof |
03/18/1997 | US5612215 Stromelysin targeted ribozymes |
03/18/1997 | US5612213 Vector for increased expression of recombinant factor viii |
03/18/1997 | US5612211 Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors |
03/18/1997 | US5612209 Allergies |
03/18/1997 | US5612206 Retrovirus infecting primate bone marrow cells and harvesting both non-adherent and adherent cells |
03/18/1997 | US5612205 Producing dna segments |
03/18/1997 | US5612201 Genetic engineering and kits for determination of gene expression |
03/18/1997 | US5612198 Production of insulin-like growth factor-1 in methylotrophic yeast cells |
03/18/1997 | US5612197 Process for producing recombinant human serum albumin |
03/18/1997 | US5612196 Introducing exogenous dna code human serum albumin and culture in medium of ethanol, glycerol, sorbitol, sucrose or esters and recovering |
03/18/1997 | US5612195 Recombinant production of a human interferon (IFN)-gamma antagonist cytokine |
03/18/1997 | US5612194 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
03/18/1997 | US5612190 Screening for vasodilators |
03/18/1997 | US5612184 Plasmids and gene complex from xenorhabdus, receptacles, hermetic sealing containers and detection of bioluminescence |
03/18/1997 | US5612180 Genetic footprinting: insertional mutagenesis and genetic selection |
03/18/1997 | US5612042 Vaccine against streptococcus suis infection |
03/18/1997 | US5612041 Recombinant herpes simplex gD vaccine |
03/18/1997 | US5612040 Non-infectious foot-and-mouth disease viruses |
03/18/1997 | US5612037 Influenza virus subunit conjugates |
03/18/1997 | US5612036 Crosslinked polypeptide vaccine with cysteine groups and carriers |
03/18/1997 | US5612035 Immunology |
03/18/1997 | US5612034 Super-globuling for in vivo extended lifetimes |
03/18/1997 | US5612030 Anti-idiotype monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma |
03/18/1997 | CA2031528C Radionuclide metal chelates for the radiolabeling of proteins |
03/15/1997 | CA2185517A1 Use of cytohesin-ph peptides for influencing the ability of integrins to adhere |
03/13/1997 | WO1997009442A1 Targeted nucleotide sequence delivery and integration system |
03/13/1997 | WO1997009438A1 Process for modifying glucose repression |
03/13/1997 | WO1997009437A1 Materials and methods relating to the attachment and display of substances on cell surfaces |
03/13/1997 | WO1997009433A1 Cell-cycle checkpoint genes |
03/13/1997 | WO1997009429A2 Compounds and methods for diagnosis of tuberculosis |
03/13/1997 | WO1997009428A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
03/13/1997 | WO1997009427A1 Vegf-related protein |
03/13/1997 | WO1997009426A1 Rna polymerase transcription factor |
03/13/1997 | WO1997009425A1 Cerebellum-derived growth factors, and uses related thereto |
03/13/1997 | WO1997009419A1 Monoclonal lymphocytes and methods of use |
03/13/1997 | WO1997009418A1 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor |
03/13/1997 | WO1997009417A1 Control of leaf scald disease |
03/13/1997 | WO1997009350A1 Purification of alpha-1 proteinase inhibitor |
03/13/1997 | WO1997009349A1 Binding protein |
03/13/1997 | WO1997009348A2 Orphan receptor |
03/13/1997 | WO1997009345A1 Virus protein purification from virosomes |
03/13/1997 | WO1997009344A2 Librairies of backbone-cyclized peptidomimetics |
03/13/1997 | WO1997009343A2 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers |
03/13/1997 | WO1997009341A1 Cyclin e variants and use thereof |
03/13/1997 | WO1997009063A1 Uses of tfpi inhibitor for treatment of cancer |
03/13/1997 | WO1997009062A1 Method of treating hypertension using animal stomach mucosa extract and endogenous protease-inhibitor peptides |
03/13/1997 | WO1997009060A1 Method of treating insulin resistance |
03/13/1997 | WO1997009055A1 Isolation of microdomains of caveolae and gpi-anchored proteins |
03/13/1997 | WO1997008947A1 Transformant |